Literature DB >> 14988859

Binding activities of infliximab and etanercept to transmembrane tumor necrosis factor-alpha.

Hiroki Mitoma, Takahiko Horiuchi, Hiroshi Tsukamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14988859     DOI： 10.1053/j.gastro.2004.01.036

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  12 in total

Review 1.  Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.

Authors:  Raja K Sivamani; Heidi Goodarzi; Miki Shirakawa Garcia; Siba P Raychaudhuri; Lisa N Wehrli; Yoko Ono; Emanual Maverakis
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 2.  TNF-α, a good or bad factor in hematological diseases?

Authors:  Tian Tian; Min Wang; Daoxin Ma
Journal:  Stem Cell Investig       Date:  2014-06-01

3.  Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting Database.

Authors:  Tomohito Wakabayashi; Keiko Hosohata; Saki Oyama; Ayaka Inada; Sayaka Ueno; Hiroko Kambara; Tatsuya Iida; Takahiro Nakatsuji; Mayako Uchida; Kazunori Iwanaga
Journal:  Ther Clin Risk Manag       Date:  2020-08-13       Impact factor: 2.423

4.  Non-response to infliximab may be due to innate neutralizing anti-tumour necrosis factor-alpha antibodies.

Authors:  E C Ebert; K M Das; V Mehta; C Rezac
Journal:  Clin Exp Immunol       Date:  2008-09-23       Impact factor: 4.330

Review 5.  Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.

Authors:  Takahiko Horiuchi; Hiroki Mitoma; Shin-ichi Harashima; Hiroshi Tsukamoto; Terufumi Shimoda
Journal:  Rheumatology (Oxford)       Date:  2010-03-01       Impact factor: 7.580

Review 6.  TNFalpha blockade in human diseases: mechanisms and future directions.

Authors:  Maida Wong; David Ziring; Yael Korin; Sheetal Desai; Sungjin Kim; Jan Lin; David Gjertson; Jonathan Braun; Elaine Reed; Ram Raj Singh
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

7.  The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease.

Authors:  Taha Qazi; Bhavesh Shah; Mohammed El-Dib; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2015-10-06       Impact factor: 3.199

8.  Reactivation of M. tuberculosis infection in trans-membrane tumour necrosis factor mice.

Authors:  Ivy Dambuza; Roanne Keeton; Nasiema Allie; Nai-Jen Hsu; Philippa Randall; Boipelo Sebesho; Lizette Fick; Valerie J F Quesniaux; Muazzam Jacobs
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

Review 9.  Anti-TNF Therapy in Spondyloarthritis and Related Diseases, Impact on the Immune System and Prediction of Treatment Responses.

Authors:  Silvia Menegatti; Elisabetta Bianchi; Lars Rogge
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 10.  TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.

Authors:  Melissa K McCoy; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2008-10-17       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.